表紙
市場調査レポート

マイクロ流体の世界市場の将来展望 (2020年)

Global Microfluids Market Outlook 2020

発行 RNCOS E-Services Pvt. Ltd. 商品コード 335668
出版日 ページ情報 英文 60 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
マイクロ流体の世界市場の将来展望 (2020年) Global Microfluids Market Outlook 2020
出版日: 2015年07月01日 ページ情報: 英文 60 Pages
概要

世界の医療分野、特にゲノム科学やドラッグデリバリの分野では、マイクロフルイディクス (微小流体技術) やラブオンチップ (lab-on-chip) 技術が徐々に普及しつつあります。マイクロフルイディクス用デバイスの潜在的市場は非常に大きいですが、現段階ではまだ実用化に至っていません。医療向けマイクロフルイディクス・デバイスの市場規模は、2014年には25億米ドルに達し、さらに2020年まで2桁台の成長率を維持する、と予測されています。巨額の研究開発 (R&D) 投資やPOC診断の精度向上、ライフサイエンス研究での需要増大などが、マイクロフルイディクス需要の促進要因となっている一方、製造技術の難しさや巨額の資本投資が、市場成長の妨げともなっています。

当レポートでは、世界のマイクロ流体市場の原状と将来展望について分析し、マイクロフルイディクスの概要や潜在的市場機会、主な市場促進・阻害要因、市場全体および用途別の動向見通し、世界各国の規制構造、主要企業のプロファイル、今後の市場動向の見通しなどについて調査・考察しております。

第1章 アナリストの見解

第2章 分析手法

第3章 マイクロフルイディクス (微小流体技術):概略

第4章 マイクロフルイディクス市場の概要

  • マイクロフルイディクス市場
  • 医療用マイクロフルイディクス市場

第5章 市場の促進要因と課題

  • 促進要因
    • 慢性疾患の発症件数増加
    • ポイントオブケア (POC) 診断の需要増加
    • ライフサイエンス研究の活用分野の拡大
    • 小型化チップの利点
  • 課題
    • ラブオンチップ装置の製造の難しさとコストの高さ
    • 不透明な規制体制
    • 新興国市場での認知度の低さ

第6章 市場の分類

  • 用途別
  • 地域別
  • 素材別

第7章 規制シナリオ

  • 米国
  • 欧州
  • アジア太平洋地域
    • インド
    • 中国

第8章 市場の動向と発展

  • マイクロフルイディクス研究向け補助金 (公表分)
  • 企業合併・買収 (M&A)

第9章 競争環境

  • Fluidigm Corporation
  • Roche Diagnostics
  • RainDance Technologies
  • Thermo Fisher Scientific
  • Agilent Technologies Inc.
  • Perkin Elmer
  • Illumina, Inc.
  • 島津製作所

図表一覧

目次

The healthcare segment is featured with microfluidic applications which refers to the flow of biological liquids through micro channels ranging from nanolitres to few picoltres. This newest approach adds several benefits to the medical world, such as large surface to volume ratio, less reagent consumption, quick diagnosis and high accuracy of the results. Thus, the emerging field of 'microfluidics or 'Lab-on-chip' is slowly penetrating into segments like genomics and drug delivery. Though microfluidic devices have the potential to be fast, cheap and portable diagnostic tools, the technology hasn't yet completely made it to the marketplace. The majority of the devices is either in the development stage or meant for research purposes.

The latest edition unveiled by RNCOS entitled "Global Microfluids Market Outlook 2020", describes the overall microfluidics industry landscape with core emphasis on healthcare applications. According to analysis, the market for healthcare microfluidic devices was worth US$ 2.5 Billion in 2014 and is poised for a double digit growth during the forecasted period (2014-2020). The new report throws light on the distribution of microfluidics technology by application, type of material and territory. In addition to this, the study covers latest trends capturing the market since last two years.

The analysis identified that rising R&D investments, proven accuracy of the microfluidics in point of care diagnostics, and increasing demand in life science research are contributing to the healthy growth of the microfluidics industry. On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector.

The key vendors dominating the market space are Fluidigm Corp., Roche, RainDance Technologies, Inc., Agilent Technologies Inc., Illumina, Inc., Shimadzu; Abbott Laboratories; GE Healthcare etc. Finally, the report covers key strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors to design suitable business strategies to target the billion dollar market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Microfluidics - An Introduction

4. Microfluidics Market Overview

  • 4.1 Microfluidics Market
  • 4.2 Healthcare Microfluidics Market

5. Drivers & Challenges

  • 5.1 Drivers
    • 5.1.1 Rising Incidence of Chronic Diseases
    • 5.1.2 Increase in Demand in Point of Care Diagnostics
    • 5.1.3 Rising Application in Lifesciences Research
    • 5.1.4 Benefits of Miniaturization of Chip
  • 5.2 Challenges
    • 5.2.1 Manufacturing Difficulties & High Cost of lab-on Chips Instruments
    • 5.2.2 Ambiguous Regulatory Framework
    • 5.2.3 Lack of Awareness in Emerging Markets

6. Market Segmentation

  • 6.1 By Applications
  • 6.2 By Geography
  • 6.3 By Material

7. Regulatory Scenario

  • 7.1 US
  • 7.2 Europe
  • 7.3 Asia-Pacific
    • 7.3.1 India
    • 7.3.2 China

8. Trends & Developments

  • 8.1 Grants Announced for Microfluidics research
  • 8.2 Mergers & Acquisitions

9. Competitive Assessment

  • 9.1 Fluidigm Corporation
  • 9.2 Roche Diagnostics
  • 9.3 RainDance Technologies
  • 9.4 Thermo Fisher Scientific
  • 9.5 Agilent Technologies Inc.
  • 9.6 Perkin Elmer
  • 9.7 Illumina, Inc.
  • 9.8 Shimadzu

List of Figures:

  • Figure 4-1: Global - Microfluidics Market (Billion US$), 2014-2020
  • Figure 4-2: Share of Healthcare in Global Microfluidics Market (%), 2014 & 2020
  • Figure 4-3: Global - Healthcare Microfluidics Market (Billion US$), 2014-2020
  • Figure 6-1: Global - Healthcare Microfluidics Market by Applications (%), 2014
  • Figure 6-2: Global - Healthcare Microfluidics Market by Geography (%), 2014
  • Figure 6-3: Global - Healthcare Microfluidics Market by Material (%), 2014
  • Figure 9-1: Fluidigm Corporation - Revenue Breakup by Geography (%), 2014
  • Figure 9-2: Roche Diagnostics- Revenue Breakup by Geography (%), 2014
  • Figure 9-3: RainDance Technologies - Revenue Breakup by Geography (%), 2014
  • Figure 9-4: Thermo Fisher Scientific - Revenue Breakup by Geography (%), 2014
  • Figure 9-5: Agilent Technologies Inc. - Revenue Breakup by Geography (%), 2014
  • Figure 9-6: Perkin Elmer- Revenue Breakup by Geography (%), 2014
  • Figure 9-7: Illumina Inc. - Revenue Breakup by Geography (%), 2014
  • Figure 9-8: Shimadzu - Revenue Break up by Geography (%), 2014

List of Tables:

  • Table 5-1: Cost Involved in Microfluidics Chips
  • Table 8-1: List of Grants Announced for Microfluidics Research (2013-2015)
  • Table 9-1: Fluidigm Corporation - Revenue by Business Segments (Million US$), 2012- 2014
  • Table 9-2: Roche Diagnostics - Revenue by Business Segments (Million US$), 2012- 2014
  • Table 9-3: RainDance Technologies - Revenue by Business Segments (Million US$), 2012- 2014
  • Table 9-4: Thermo Fisher Scientific - Revenue by Business Segments (Million US$), 2012- 2014
  • Table 9-5: Agilent Technologies Inc. - Revenue by Business Segments (Million US$), 2012- 2014
  • Table 9-6: Perkin Elmer - Revenue by Business Segments (Million US$), 2012- 2014
  • Table 9-7: Illumina Inc. - Revenue by Business Segments (Million US$), 2012- 2014
  • Table 9-8: Shimadzu - Revenue by Business Segments (Million US$), 2012- 2014
Back to Top